Gene Editing Used to Enhance AML Antigen Targeting for CAR T-Cell Therapy
Siddhartha Mukherjee, MD, discusses potential means of targeting chimeric antigen receptor T-cell therapy for patients with acute myeloid leukemia.
Discussing Therapeutic Options For Patients With AML
Siddhartha Mukherjee, MD, explains the current golden standard for frontline treatment of patients with acute myeloid leukemia.